Capital International Investors now owns 21,931,225 shares of the medical research company’s stock valued at $2,841,315,000 after purchasing an additional 1,250,416 shares during the last quarter. Capital International Investors raised its holdings in shares of Edwards Lifesciences by 6.0% in the fourth quarter. State Street Corp now owns 26,920,713 shares of the medical research company’s stock valued at $3,487,578,000 after purchasing an additional 948,638 shares during the last quarter. State Street Corp raised its holdings in shares of Edwards Lifesciences by 3.7% in the fourth quarter. now owns 57,040,983 shares of the medical research company’s stock valued at $7,389,659,000 after purchasing an additional 4,007,132 shares during the last quarter. raised its holdings in shares of Edwards Lifesciences by 7.6% in the fourth quarter. Peregrine Capital Management LLC’s holdings in Edwards Lifesciences were worth $52,721,000 as of its most recent SEC filing.Ī number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Edwards Lifesciences comprises approximately 1.2% of Peregrine Capital Management LLC’s holdings, making the stock its 10th largest position.
The institutional investor owned 447,855 shares of the medical research company’s stock after selling 37,938 shares during the period. ( NYSE:EW – Get Rating) by 7.8% during the 1st quarter, reports.
Peregrine Capital Management LLC decreased its holdings in shares of Edwards Lifesciences Co.
0 kommentar(er)
